Skip to main content
Top

Current Oncology Reports

Issue 4/2017

Content (8 Articles)

Palliative Medicine (A Jatoi, Section Editor)

Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies

Masayuki Futagami, Yoshihito Yokoyama, Muneaki Shimada, Shinya Sato, Etsuko Miyagi, Akiko Tozawa-Ono, Nao Suzuki, Masaki Fujimura, Yoichi Aoki, Satoru Sagae, Toru Sugiyama

Leukemia (A Aguayo, Section Editor)

Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment

Aude Collignon, Anne Wanquet, Elsa Maitre, Edouard Cornet, Xavier Troussard, Thérèse Aurran-Schleinitz

Lymphomas (MR Smith, Section Editor)

Genetic Landscape and Classification of Peripheral T Cell Lymphomas

Rosalind F. Sandell, Rebecca L. Boddicker, Andrew L. Feldman

Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors)

Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions

Hussein Merza, Marijo Bilusic

Open Access Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors)

The Role of Hypofractionated Radiotherapy in Prostate Cancer

Linus C. Benjamin, Alison C. Tree, David P. Dearnaley

Neuro-oncology (S Nagpal, Section Editor)

The Effect of Molecular Diagnostics on the Treatment of Glioma

Nancy Ann Oberheim Bush, Nicholas Butowski

Neuro-oncology (S Nagpal, Section Editor)

Immune Checkpoint Inhibitors in Gliomas

Aaron C. Tan, Amy B. Heimberger, Mustafa Khasraw

Lung Cancer (JM Johnson, Section Editor)

Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to Therapy

Joshua K. Sabari, Fernando Santini, Isabella Bergagnini, W. Victoria Lai, Kathryn C. Arbour, Alexander Drilon

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine